Rockwell Medical (Rockwell Medical) Days Sales Outstanding

: 41.84 (As of Dec. 2023)

View and export this data going back to 1998. Start your Free Trial

Rockwell Medical's average Accounts Receivable for the three months ended in Dec. 2023 was $10.13 Mil. Rockwell Medical's Revenue for the three months ended in Dec. 2023 was $22.09 Mil. Hence, Rockwell Medical's Days Sales Outstanding for the three months ended in Dec. 2023 was 41.84.

The historical rank and industry rank for Rockwell Medical's Days Sales Outstanding or its related term are showing as below:

RMTI' s Days Sales Outstanding Range Over the Past 10 Years
Min: 24.57 Med: 32.34 Max: 40.61
Current: 33.14

During the past 13 years, Rockwell Medical's highest Days Sales Outstanding was 40.61. The lowest was 24.57. And the median was 32.34.

RMTI's Days Sales Outstanding is ranked better than
85.81% of 1001 companies
in the Drug Manufacturers industry
Industry Median: 71.93 vs RMTI: 33.14

Rockwell Medical's Days Sales Outstanding increased from Dec. 2022 (32.19) to Dec. 2023 (41.84).

Rockwell Medical Days Sales Outstanding Historical Data

The historical data trend for Rockwell Medical's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rockwell Medical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

33.29

24.57

29.72

30.51

37.46

Rockwell Medical Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding																32.19	28.49	28.85	28.35	41.84

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Rockwell Medical's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rockwell Medical Days Sales Outstanding Distribution

For the Drug Manufacturers industry and Healthcare sector, Rockwell Medical's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Rockwell Medical's Days Sales Outstanding falls into.

Rockwell Medical Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Rockwell Medical's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (6.259	+	10.901)	/	2 )	/	83.612	*	365
=	8.58					/	83.612	*	365
=	37.46

Rockwell Medical's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (9.361	+	10.901)	/	2 )	/	22.093	*	365 / 4
=	10.131					/	22.093	*	365 / 4
=	41.84

Rockwell Medical (NAS:RMTI) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Rockwell Medical Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Rockwell Medical's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Rockwell Medical (Rockwell Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rockwell Medical Inc (NAS:RMTI) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

RWMA:Germany

Address

30142 S. Wixom Road, Wixom, MI, USA, 48393

Website

https://www.rockwellmed.com

Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. Rockwell Medical's mission is to provide dialysis clinics and patients with the highest quality products supported by the best customer service in the industry. It is focused on innovative, long-term growth strategies that enhance products, processes, and people, enabling the company to deliver exceptional value to the healthcare system and provide a positive impact on the lives of hemodialysis patients.

Executives

Jesse Neri	officer: SVP, FINANCE	851 DUPORTAIL ROAD, SECOND FLOOR, CHESTERBROOK PA 19087
Joan Lau	director	C/O RENOVACOR, INC., 5 MEAD POINT DRIVE, GREENWICH CT 06830
Russell Skibsted	officer: See Remarks	15 TRANQUILITY PLACE, LADERA RANCH CA 92694
Megan C. Timmins	officer: SVP, General Counsel	600 LEE ROAD, SUITE 100, WAYNE PA 19087
Mark Strobeck	director, officer: President and CEO	460 EAST SWEDESFORD ROAD, SUITE 1050, WAYNE PA 19087
Allen Nissenson	director	601 HAWAII ST., EL SEGUNDO CA 90245
Robert S Radie	director	101 LINDENWOOD DRIVE, SUITE 225, MALVERN PA 19355
Andrea Heslin Smiley	director	600 LEE ROAD, SUITE 100, WAYNE PA 19087
David S. Richmond	10 percent owner, other: See Footnote 1	3568 WILDWOOD AVENUE, JACKSON MI 49202
Russell H Ellison	director	270 RIVERSIDE DR., APT. 12D, NEW YORK NY 10025
Marc L Hoffman	officer: Chief Medical Officer	30142 WIXOM ROAD, WIXOM MI 48393
John Peter Mclaughlin	director	C/O PDL BIOPHARMA, INC., 932 SOUTHWOOD BOULEVARD, INCLINE VILLAGE NV 89451
Richmond Brothers, Inc.	10 percent owner, other: See Footnote 1	7415 FOXWORTH COURT, JACKSON MI 49201
Stuart M Paul	director, officer: Chief Executive Officer	HOME DIAGNOSTICS, INC., 2400 NW 55TH COURT, FORT LAUDERDALE FL 33309
Angus W. Smith	officer: Chief Financial Officer	C/O PERNIX THERAPEUTICS HOLDINGS, INC., 10 NORTH PARK PLACE, SUITE 201, MORRISTOWN NJ 07960